More reads
- Major study finds common steroid reduces deaths among patients with severe Covid-19. (STAT)
- Neurocrine bets $2B on Takeda's psychiatry drugs. (BioPharma Dive)
- Biotech share gains on virus leave some investors skeptical. (Bloomberg)
- As quality concerns rise, FDA report shows Indian drug plants inspected more often — and had more problems. (STAT Plus)
No hay comentarios:
Publicar un comentario